Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme

Food and Chemical Toxicology

Volumn 44, Issue 8, 2006, Pages 1213-1222

  Lea, L J ^a   Hepburn, P A ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

Functional foods; Novel foods; Phytosterols; Plant sterols; Post launch monitoring

Indexed keywords

CAROTENOID; ESTER; PHYTOSTEROL ESTER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CONSUMER; HUMAN; RISK ASSESSMENT;

CAROTENOIDS; DOUBLE-BLIND METHOD; ESTERS; EUROPEAN UNION; FEMALE; HUMANS; MALE; MARGARINE; MIDDLE AGED; PHYTOSTEROLS; PLANT OILS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 33745207105     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.01.017     Document Type: Article

References (43)

1. Albanes D., Virtamo J., Taylor P.R., Rautalahati M., Pietinen P., and Heinonen O.P. Effects of supplemental β-carotene, cigarette smoking, and alcohol smoking on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 66 (1997) 366-372
2. Allgood G.S., Kuter D.J., Roll K.T., Taylor S.L., and Zorich N.L. Poatmarketing surveillance of new food ingredients: results from the program with the fat replacer olestra. Regul. Toxicol. Pharmacol. 33 (2001) 224-233
3. Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Eng. J. Med. 330 (1994) 1029-1035
4. Amanor-Boadu V. Post-market surveillance model for potential human health effects of novel foods. Food Policy 29 (2004) 609-620
5. Ayesh R., Weststrate J.A., Drewitt P.N., and Hepburn P.A. Safety evaluation of phytosterol-esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and plasma female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol-ester enriched margarine. Food Chem. Tox. 37 (1999) 1127-1138
6. Baker V.A., Hepburn P.A., Kennedy S.J., Jones P.A., Lea L.J., Sumpter J.P., and Ashby J. Safety evaluation of phytosterol-esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food Chem. Tox. 37 (1999) 13-22
7. Butchko H.H., and Stargel W.W. Aspartame: scientific evaluation in the postmarketing period. Regul. Toxicol. Pharmacol. 34 (2001) 221-233
8. EC, 2000. Commission Decision of 24 July 2000 on authorising the placing on the market of 'yellow fat spreads with added phytosterol-esters' as a novel food or food ingredient under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2000/500/EC. Off. J. Eur. Commun. L200, 59-60 (8 August 2000).
9. EC, 2004a. Commission Decision of 31 March 2004 authorising the placing on the market of yellow fat spreads, salad dressings, milk type products, fermented milk type products, soya drinks and cheese type products with added phytosterols/phytostanols as novel foods or novel food ingredients under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2004/333/EC. Off. J. Eur. Union L105, 40-42 (14 April 2004).
10. EC, 2004b. Commission Decision of 31 March 2004 authorising the placing on the market of yellow fat spreads, milk type products, yoghurt type products, and spicy sauces with added phytosterols/phytostanols as novel foods or novel food ingredients under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2004/334/EC. Off. J. Eur. Union L105, 43-45 (14 April 2004).
11. EC, 2004c. Commission Decision of 31 March 2004 authorising the placing on the market of milk and yoghurt type products with added phytosterol-esters as novel food ingredients under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2004/335/EC. Off. J. Eur. Union L105, 46-48 (14 April 2004).
12. EC, 2004d. Commission Decision of 31 March 2004 authorising the placing on the market of yellow fat spreads, milk based fruit drinks, yoghurt type products and cheese type products with added phytosterols/phytostanols as novel foods or novel food ingredients under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2004/336/EC. Off. J. Eur. Union L105, 49-51 (14 April 2004).
13. EC, 2004e. Commission Decision of 12 November 2004 authorising the placing on the market of milk based beverages with added phytosterols/phytostanols as novel foods or novel food ingredients under Regulation (EC) No. 258/97 of the European Parliament and of the Council. 2004/845/EC. Off. J. Eur. Union L366, 14-16 (11 December 2004).
14. Greenberg E.R., Baron J.A., Tosteson T.D., Freeman D.H., Beck G.J., Bond J.H., Colacchio T.A., Coller J.A., Frankl H.D., Haile R.W., Mandel J.S., Nierenberg D.W., Rothstein R., Snover D.C., Stevens M.M., Summers R.W., van Stolk R.U., and for the Polyp Prevention Study Group. A clinical trial of antioxidant vitamins to prevent colorectal adenomas. New Engl. J. Med. 331 (1994) 141-147
15. Heinonen O.P., Albanes D., Virtamo J., Taylor P.R., Huttunen J.K., Hartman A.M., Haapakoski J., Malila N., Rautalahti M., Ripatti S., Maenpaa H., Teerenhovi L., Koss L., Virolainen M., and Edwards B.K. Prostate cancer and supplementation with a-tocopherol and b-carotene: incidence and mortality in a controlled trial. J. Nat. Cancer Inst. 90 (1998) 440-446
16. Hendricks H.F.J., Weststrate J.A., Van Vliet T., and Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 53 (1999) 319-327
17. Hendricks H.F.J., Brink E.J., Meijer G.W., Princen H.M.G., and Ntanios F.Y. Safety of long-term consumption of plant sterol-esters enriched spread. Eur. J. Clin. Nutr. 57 (2003) 681-692
18. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., Belanger C., LaMotte F., Gaziano J.M., Ridker P.M., Willett W., and Peto R. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasma and cardiovascular disease. New Eng. J. Med. 334 (1996) 1145-1149
19. Hepburn P.A., Horner S.A., and Smith M. Safety evaluation of phytosterol-esters. Part 2. Subchronic 90-day oral toxicity study on phytosterol-esters-a novel functional food. Food Chem. Tox. 37 (1999) 521-532
20. Hlywka J.J., Reid J.E., and Munro I.C. The use of consumption data to assess exposure to biotechnology-derived foods and the feasibility of identifying effects on human health through post-market monitoring. Food Chem. Tox. 41 (2003) 1273-1282
21. Law M.R., and Morris J.K. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?. Eur. J. Clin. Nutr. 52 (1998) 549-556
22. Lea L.J., and Hepburn P.A. Cholesterol lowering vegetable oil spreads: results of a Post Launch Monitoring Programme. Proceedings of the Deutsche Forschungsgemeinschaft, Functional Foods: Safety Aspects Symposium, 5-7 May 2002 (2004), Wiley-VCH, New York
23. Lea L.J., Hepburn P.A., Wolfreys A.M., and Baldrick P. Safety evaluation of phytosterol-esters. Part 8. Lack of genotoxicity and subchronic toxicity of phytosterol oxides. Food Chem. Tox. 42 (2004) 771-783
24. MacLennan R., Macrae F., Bain C., Battistutta D., Chapuis P., Gratten H., Lambert J., Newland R.C., Ngu M., Russell A., Ward M., Wahlqvist M.L., and the Australian Polyp Prevention Project. Randomized trial of intake of fat, fibre and beta-carotene to prevent colorectal adenomas. J. Nat. Cancer Inst. 87 (1995) 1760-1766
25. Maki K.C., Davidson M.H., Umporowicz D.M., Schaefer E.F., Dicklin M.R., Ingram K.A., Chen S., McNamara J.R., Gebhart B.W., Ribaya-Mercado J.D., Perrone G., Robins S.J., and Franke W.C. Lipid responses to plant sterol enriched spread reduced fat spreads incorporated into a National Cholesterol Education Program Step 1 diet. Am. J. Clin. Nutr. 74 (2001) 33-43
26. Neil H.A.W., Meijer G.W., and Roe L.S. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156 (2001) 329-337
27. Ness A.R., and Powles J.W. Fruit and vegetables, and cardiovascular disease: a review. Int. J. Epidemiol. 26 (1997) 1-13
28. Noakes M., Clifton P., Ntanios F., Shrapnel W., Record I., and McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid levels. Am. J. Clin. Nutr. 75 (2002) 79-86
29. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., and Hammar S. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. New Eng. J. Med. 334 (1996) 1150-1155
30. Rapola J.M., Virtamo J., Haukka J.K., Heinonen O.P., Albanes D., Taylor P.R., and Huttunen J.K. Effect of vitamin E and beta-carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. J. Am. Med. Assoc. 275 (1996) 693-698
31. Rapola J.M., Virtamo J., Ripatti S., Huttunen J.K., Albanes D., Taylor P.R., and Heinonen O.P. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349 (1997) 1715-1720
32. Sanders D.J., Minter H.J., Howes D., and Hepburn P.A. Safety evaluation of phytosterol esters, Part 6, 2000. The comparative absorption and tissue distribution of phytosterols in the rat. Food Chem. Tox. 38 (2000) 485-491
33. SCF, 2000. Opinion of the Scientific Committee on food on a request for the safety assessment of the use of phytosterol esters in yellow fat spreads, 6th April 2000. SCF/CS/NF/DOS/1 FINAL. European Commission, Health and Consumer Protection Directorate General, Brussels.
34. SCF, 2002. Opinion of the Scientific Committee on food on a report on Post Launch Monitoring of 'yellow fat spreads with added phytosterol-esters', 4th October 2002. SCF/CS/NF/DOS/21 ADD 2 FINAL. European Commission, Health and Consumer Protection Directorate General, Brussels.
35. Slough C.L., Miday R.K., Zorich N.L., and Jones J.K. Postmarketing surveillance of new food ingredients: design and implementation of the program for the fat replacer olestra. Regul. Toxicol. Pharmacol. 33 (2001) 218-223
36. Steinmetz K.A., and Potter J.D. Vegetables, fruit and cancer prevention: a review. J. Am. Diet. Assoc. 96 (1996) 1027-1039
37. Vainio H., and Rautalahti M. An international evaluation of the cancer preventive potential of carotenoids. Cancer Epidemiol., Biomark. Prevention 7 (1998) 725-728
38. Varis K., Taylor P.R., Sipponen P., Samloff I.M., Heinonen O.P., Albanes D., Harkonen M., Huttunen J.K., Laxen F., Virtamo J., and the Helsinki Gastritis Study Group. Gastric cancer and pre-malignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. Scand. J. Gastroenterol. 33 (1998) 294-300
39. Waalkens-Berendsen D.H., Wolterbeek A.P.M., Wijnands M.V.W., Richold M., and Hepburn P.A. Safety evaluation of phytosterol-esters, part 3: two-generation reproduction study in rats with phytosterol-esters-a novel functional food. Food Chem. Tox. 37 (1999) 683-696
40. Wal J.-M., Hepburn P.A., Lea L.J., and Crevel R.W.R. Post-market surveillance of GM foods: applicability and limitations of schemes used with pharmaceuticals and some non-GM novel foods. Reg. Tox. Pharm. 38 (2003) 98-104
41. Westrate J.A., and Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 52 (1998) 334-343
42. Weststrate J.A., Ayesh R., Bauer-Plank C., and Drewitt P.N. Safety evaluation of Phytosterol-esters. Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolpidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem. Tox. 37 (1999) 1063-1071
43. Wolfreys A.M., and Hepburn P.A. Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol-esters and the cholesterol derivative, 4-cholesten-3-one. Food Chem. Tox. 40 (2002) 461-470